Notes from the Field: Supply Interruptions of First- and Second-Line Oral Drugs to Treat Tuberculosis During the Previous 12 Months — California, January–March, 2023
by from Morbidity and Mortality Weekly Report (MMWR) on (#6HJJ7)
This report describes a survey among tuberculosis (TB) programs in California to assess delays and shortages of TB drugs.